| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 04/15/2004 | WO2004031151A1 Compounds capable of activating cholinergic receptors |
| 04/15/2004 | WO2004031137A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 04/15/2004 | WO2004030635A2 Vasculostatic agents and methods of use thereof |
| 04/15/2004 | WO2004030629A2 Novel neurokinin antagonists and methods of use thereof |
| 04/15/2004 | WO2004020417A8 2,4-diaminoquinazoline, 2-amino-4-hydroxypteridine and 2,4-diaminopyrimidine ester derivatives as dihydrofolate reductase inhibitors |
| 04/15/2004 | WO2004018436A3 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
| 04/15/2004 | US20040072880 Cycloalkyl inhibitors of potassium channel function |
| 04/15/2004 | US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders |
| 04/15/2004 | US20040072852 Anticholesterol agents; cardiovascular disorders |
| 04/15/2004 | US20040072850 Caspase inhibitors and uses thereof |
| 04/15/2004 | US20040072770 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 04/15/2004 | US20040071697 Reducing epithelial toxicity during cancer therapy |
| 04/15/2004 | CA2503674A1 Quinazolin-4-one derivatives |
| 04/15/2004 | CA2501063A1 Substrates for o6-alkylguanine-dna alkyltransferase |
| 04/15/2004 | CA2500727A1 Vasculostatic agents and methods of use thereof |
| 04/14/2004 | EP1407774A1 2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds |
| 04/14/2004 | EP1406876A1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 04/14/2004 | EP1406875A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/14/2004 | EP1406622A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/14/2004 | EP1406620A1 Vinyl phenyl derivatives as glk activators |
| 04/14/2004 | EP0892790B1 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use |
| 04/14/2004 | CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives |
| 04/14/2004 | CN1489576A Cannabinod receptor ligands |
| 04/14/2004 | CN1489458A Inhibitors against the production and releaseof inflammator cytokines |
| 04/14/2004 | CN1489437A Herbicidal agent |
| 04/14/2004 | CN1488626A 2-pyrimidine oxy-N-ureido phenyl-benzyl amide compound, preparing method and use thereof |
| 04/14/2004 | CN1145627C Pyrazolo [4,3-d] pyrimidines |
| 04/14/2004 | CN1145625C Process for the production of tert-buty1 (E)-(6[2-[4-(4-fluorophenyl)-6-isopropyl-2[methyl(methyl sulfonyl)amino]pyrimidin5-yl](4R,65)-2,2-dimethyl[1,3]dioxan-4-yl]acetate ]) |
| 04/14/2004 | CN1145614C Irreversible inhibitors of tyrosine kinases, its pharmaceutical use and medicine composition thereof |
| 04/14/2004 | CN1145613C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing same |
| 04/14/2004 | CN1145610C Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 04/14/2004 | CN1145609C Piperazine compounds and medical use thereof |
| 04/13/2004 | US6720421 Storage stability: good raw-stock storability before recording and good image storability after recording |
| 04/13/2004 | US6720338 Bcl-x1 inhibiting compositions and methods of promoting apoptosis in a mammal |
| 04/13/2004 | US6720335 Sulfonamide inhibitors of aspartyl protease |
| 04/13/2004 | US6720322 Use as endothelin receptor antagonists. |
| 04/13/2004 | US6720321 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 04/13/2004 | US6720315 Dihydrostilbene alkanoic acid derivatives |
| 04/13/2004 | US6719339 Vehicle protection assembly |
| 04/13/2004 | CA2149239C Herbicidal sulfonylureas, their preparation and use |
| 04/08/2004 | WO2004029204A2 Substituted pyrimidines |
| 04/08/2004 | WO2004029045A2 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof |
| 04/08/2004 | WO2004029044A1 Pyrimidine compounds as therapeutic agents |
| 04/08/2004 | WO2004029030A1 Pyrimidine derivative and herbicide containing the same |
| 04/08/2004 | WO2004028452A2 Method for preparing crambescidin core acid intermediates and their use for preparing crambescidin alkaloid analogs as therapeutic agents |
| 04/08/2004 | WO2004000318A3 Certain amino-substituted monocycles as kinase modulators |
| 04/08/2004 | WO2003105854A3 Substituted dihydropyrimidines and dihydropyrimidinethiones as calcium channel blockers |
| 04/08/2004 | US20040068113 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 04/08/2004 | US20040068016 C2-substituted idan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals |
| 04/08/2004 | US20040068001 Using hydroxy-3-methylglutaryl/3-/ coenzyme inhibitor |
| 04/08/2004 | US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof |
| 04/08/2004 | US20040067970 Cooling sensation; food, dentifrices, mouthwash |
| 04/08/2004 | US20040067969 Syntheses of quinazolinones |
| 04/08/2004 | US20040067927 Substituted alkyldiamines |
| 04/08/2004 | US20040065866 Low viscosity; solubility at low temperature; low voltage display device |
| 04/08/2004 | CA2751086A1 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof |
| 04/08/2004 | CA2499497A1 Substituted pyrimidines |
| 04/07/2004 | EP1404860A2 Delivery system for nucleic acids |
| 04/07/2004 | EP1404668A1 Variolin derivatives and their use as antitumor agents |
| 04/07/2004 | EP1404337A2 QUINAZOLINE AND PYRIDO 2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 04/07/2004 | EP1305281B1 Substituted sulfonyl aminomethyl benzoic acid (derivatives) and method for the production thereof |
| 04/07/2004 | EP1158858B1 Formulation of herbicides and plant growth regulators |
| 04/07/2004 | EP1131270B1 Process for converting an alcohol to the corresponding fluoride |
| 04/07/2004 | EP1100766B1 Crosslinkable liquid crystalline compounds |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/07/2004 | CN1144587C Agents for relieving side effects |
| 04/06/2004 | US6716981 Process for the preparation of N-(amino-4, 6-dihalo-pyrimidine) formamides |
| 04/06/2004 | US6716878 Antimicrobial agents |
| 04/06/2004 | US6716851 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof |
| 04/06/2004 | US6716847 Antiallergens, antiinflammatory |
| 04/06/2004 | US6716845 Barbituric acid derivatives |
| 04/06/2004 | US6716838 Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| 04/06/2004 | US6716831 2,4-diamino-pyrimidine deprivatives having anti-cell proliferative activity |
| 04/06/2004 | CA2223927C Detection of transmembrane potentials by optical methods |
| 04/06/2004 | CA2124306C Quinazolinone derivatives |
| 04/01/2004 | WO2004026881A1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments |
| 04/01/2004 | WO2004026842A1 Novel uracil derivatives and medicinal use thereof |
| 04/01/2004 | WO2004026841A1 Novel 6-substituted uracil derivative and therapeutic agent for allergic disease |
| 04/01/2004 | WO2004026840A1 Tetrahydropyrimidine-2-one derivatives and their uses |
| 04/01/2004 | WO2004026818A1 New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors |
| 04/01/2004 | WO2004009559A3 Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents |
| 04/01/2004 | WO2003104440A3 2,2-bis(hydroxymethyl)cyclopropylidenemethyl - purines and -pyrimidines as antiviral agents |
| 04/01/2004 | WO2003099771A3 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2002102314A3 Purine inhibitors of phosphodiesterase (pde) 7 |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063945 6-(1-fluoroethyl)-5-iodo-4-aminopyrimidine compounds process for preparation of the same and pest controllers for agricultural and horticultural use |
| 04/01/2004 | US20040063936 Pyrimidine derivatives and process for preparing the same |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063755 Aromatic compounds containing hydroxyalkylaminoalkylphenylaminophenyl group; useful for treating pre-term labor, neurological disorders and cardiac disorders |
| 04/01/2004 | US20040063734 4,4-Disubstituted-3,4-dihydro-2 (1H)-quinazoliniones useful as HIV reverse transcriptase inhibitors |
| 04/01/2004 | US20040063690 Cardiovascular disorders; guanylate cyclase activation; diseases associated with disturbed cyclic guanosine monophosphate balance |
| 04/01/2004 | US20040063684 Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 04/01/2004 | US20040063679 Amidino and guanidino peptidyl compounds; autoimmune diseases |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063673 Specific MMP-13 enzyme inhibitors; tissue breakdown diseases |
| 04/01/2004 | US20040063643 Bombesin antagonists |
| 04/01/2004 | US20040060568 Hedgehog antagonists, methods and uses related thereto |
| 04/01/2004 | US20040060474 Ink jet, especially piezoelectric, printing |